US Stem Cell Inc (USRM)

[trading.jeff]

I wouldn't be surprised if $USRM runs tomorrow on these points:

CONVERTIBLE NOTES PAID OFF!

* Revenue up by 62% from $710,000 in Q1 2016 to $1.15M in Q1 2017
* Gross profit up by 45.6% from $556,000 in Q1 2016 to $810,000 in Q1 2017
* Cash Flow is positive Q1 2017 at $268,000 compared to Q1 2016 at ($62,000)
* All debt-to-equity convertible notes have been either fully paid or converted as of March 31, 2017.

Of course, there will be those who were hoping for a 62.1% increase in revenue and gross profit up 45.7%.